BACKGROUND AND AIMS: Fatty liver is the hepatic manifestation of obesity, but community-based assessment of fatty liver among unselected patients is limited. We sought to determine the feasibility of and optimal protocol for quantifying fat content in the liver in the Framingham Heart Study using multidetector computed tomography (MDCT) scanning. METHODS: Participants (n = 100, 49% women, mean age 59.4 years, mean body mass index 27.8 kg/m(2)) were drawn from the Framingham Heart Study cohort. Two readers measured the attenuation of the liver, spleen, paraspinal muscles, and an external standard from MDCT scans using multiple slices in chest and abdominal scans. RESULTS: The mean measurement variation was larger within a single axial computed tomography (CT) slice than between multiple axial CT slices for the liver and spleen, whereas it was similar for the paraspinal muscles. Measurement variation in the liver, spleen, and paraspinal muscles was smaller in the abdomen than in the chest. Three versus six measures of attenuation in the liver and two versus three measures in the spleen gave reproducible measurements of tissue attenuation (intraclass correlation coefficient [ICCC] of 1 in the abdomen). Intra reader and interreader reproducibility (ICCC) of the liver-to-spleen ratio was 0.98 and 0.99, the liver-to-phantom ratio was 0.99 and 0.99, and the liver-to-muscle ratio was 0.93 and 0.86, respectively. CONCLUSION: One cross-sectional slice is adequate to capture the majority of variance of fat content in the liver per individual. Abdominal scan measures as compared to chest scan measures of fat content in the liver are more precise. The measurement of fat content in the liver on MDCT scans is feasible and reproducible.
BACKGROUND AND AIMS: Fatty liver is the hepatic manifestation of obesity, but community-based assessment of fatty liver among unselected patients is limited. We sought to determine the feasibility of and optimal protocol for quantifying fat content in the liver in the Framingham Heart Study using multidetector computed tomography (MDCT) scanning. METHODS:Participants (n = 100, 49% women, mean age 59.4 years, mean body mass index 27.8 kg/m(2)) were drawn from the Framingham Heart Study cohort. Two readers measured the attenuation of the liver, spleen, paraspinal muscles, and an external standard from MDCT scans using multiple slices in chest and abdominal scans. RESULTS: The mean measurement variation was larger within a single axial computed tomography (CT) slice than between multiple axial CT slices for the liver and spleen, whereas it was similar for the paraspinal muscles. Measurement variation in the liver, spleen, and paraspinal muscles was smaller in the abdomen than in the chest. Three versus six measures of attenuation in the liver and two versus three measures in the spleen gave reproducible measurements of tissue attenuation (intraclass correlation coefficient [ICCC] of 1 in the abdomen). Intra reader and interreader reproducibility (ICCC) of the liver-to-spleen ratio was 0.98 and 0.99, the liver-to-phantom ratio was 0.99 and 0.99, and the liver-to-muscle ratio was 0.93 and 0.86, respectively. CONCLUSION: One cross-sectional slice is adequate to capture the majority of variance of fat content in the liver per individual. Abdominal scan measures as compared to chest scan measures of fat content in the liver are more precise. The measurement of fat content in the liver on MDCT scans is feasible and reproducible.
Authors: Mark A Tarnopolsky; Courtney D Rennie; Holly A Robertshaw; Stephanie N Fedak-Tarnopolsky; Michaela C Devries; Mazen J Hamadeh Journal: Am J Physiol Regul Integr Comp Physiol Date: 2006-11-09 Impact factor: 3.619
Authors: Elizabeth K Speliotes; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; James B Meigs; Dushyant V Sahani; Joel N Hirschhorn; Christopher J O'Donnell; Caroline S Fox Journal: Hepatology Date: 2010-06 Impact factor: 17.425
Authors: John F O'Sullivan; Jordan E Morningstar; Qiong Yang; Baohui Zheng; Yan Gao; Sarah Jeanfavre; Justin Scott; Celine Fernandez; Hui Zheng; Sean O'Connor; Paul Cohen; Ramachandran S Vasan; Michelle T Long; James G Wilson; Olle Melander; Thomas J Wang; Caroline Fox; Randall T Peterson; Clary B Clish; Kathleen E Corey; Robert E Gerszten Journal: J Clin Invest Date: 2017-10-30 Impact factor: 14.808
Authors: Rajesh Tota-Maharaj; Michael J Blaha; Irfan Zeb; Ronit Katz; Ron Blankstein; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir Journal: Mayo Clin Proc Date: 2014-03-07 Impact factor: 7.616
Authors: Robert M Wilechansky; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Emelia J Benjamin; Michelle T Long Journal: Liver Int Date: 2019-05-24 Impact factor: 5.828
Authors: Ali F Jon; Ahmad R Cheema; Atif N Khan; Vassilios Raptopoulos; Thomas Hauser; Imad Nasser; Francine K Welty; Andrew Karellas; Melvin E Clouse Journal: Clin Imaging Date: 2014-01-17 Impact factor: 1.605
Authors: Michelle T Long; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Jiantao Ma; Rohit Loomba; Raymond T Chung; Emelia J Benjamin Journal: Liver Int Date: 2018-03-12 Impact factor: 5.828
Authors: Faisal Khosa; Atif N Khan; Khurram Nasir; Arash Bedayat; Zehra Malik; Ali F Jon; Ahmad R Cheema; Melvin E Clouse; Francine K Welty Journal: Atherosclerosis Date: 2012-12-13 Impact factor: 5.162